No Photo Available

Last Update

2017-02-01T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Kevin Starr?

Mr. Kevin P. Starr

Chief Operating Officer and Chief Financial Officer

Millennium Pharmaceuticals , Inc.

Direct Phone: (617) ***-****       

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Millennium Pharmaceuticals , Inc.

40 Landsdowne Street

Cambridge, Massachusetts 02139

United States

Company Description

Millennium: The Takeda Oncology Company , a leading biopharmaceutical company based in Cambridge, Mass., markets a first-in-class proteasome inhibitor in the US, and has a robust clinical development pipeline of global product candidates. Millennium Pharm ... more

Find other employees at this company (525)

Background Information

Employment History

Partner

Third Rock Ventures LLC

Various Executive Roles

Biogen Idec Inc.

Board Member, Interim Chief Executive Officer

Ember Therapeutics Inc

Director

Vitae Pharmaceuticals , Inc.

Affiliations

Board Member
Alnylam Pharmaceuticals , Inc.

Board Member
AGIOS PHARMACEUTICALS INC

Board Member
ZAFGEN, INC.

Board Member
Afferent Pharmaceuticals Inc

Board Member
PanOptica Inc

Chief Executive Officer
Sage Therapeutics, Inc.

Board Member
Global Blood Therapeutics, Inc.

Board Member
MyoKardia Inc

ADVISORY BOARD Member
Palo Alto Investors LLC

Member
Board

Managing Member
TRV GP , LLC

Board Member
Cell Therapy News

Board Member
Konarka Technologies Inc

Board Member
Human Genome Sciences , Inc.

Position In Audit Committee
The CMT Foundation

Board Member
Shareholder.com incorporated

Board Member
Info.Resource , Inc.

Board Member
MarylandLifeScience.com

Board Member
MichiganLifeScience.com

Board Member
Utah Life Science Association

Board Member
KentuckyLifeScience.com

Board Member
ArkansasLifeScience.com

Board Member
Washington Biotechnology & Biomedical Association

Board Member
IndianaLifeScience.com

Board Member
KansasLifeScience.com

Board Member
ConnecticutLifeScience.com

Board Member
MaineLifeScience.com

Board Member
MinnesotaLifeScience.com

Board Member
HawaiiLifeScience.com

Board Member
WisconsinLifeScience.com

Board Member
IllinoisLifeScience.com

Board Member
NewYorkLifeScience.com

Board Member
FloridaLifeScience.com

Board Member
NorthCarolinaLifeScience.com

Board Member
OhioLifeScience.com

Board Member
NebraskaLifeScience.com

Board Member
MontanaLifeScience.com

Board Member
NewJerseyLifeScience.com

Board Member
AlaskaLifeScience.com

Board Member
WyomingLifeScience.com

Board Member
NewMexicoLifeScience.com

Board Member
IdahoLifeScience.com

Board Member
MassachusettsLifeScience.com

Board Member
GeorgiaLifeScience.com

Board Member
Oregon Bioscience Association

Board Member
BritishColumbiaLifeScience.com

Board Member
AlbertaLifeScience.com

Board Member
Cambridge Savings Bank

Board Member
Concurrent Pharmaceuticals , Inc.

Board Member
Faber Daeufer Itrato & Cabot

Board Member
RNA company

Board Member
VoiceSignal Technologies Inc

Board Member
Encysive Pharmaceuticals

Board Member
ColoradoLifeScience.com

Board Member
PennsylvaniaLifeScience.com

Board Member
CaliforniaLifeScience.com

Education

BA

Brandeis University

Bachelor of Arts degree

Mathematics and Business

Colby College

M.D.

MBA

Bentley University

Master of Science degree

Corporate Finance

Boston College

Web References (118 Total References)


Panoptica | Who We Are | Board of Directors

www.panopticapharma.com [cached]

Kevin Starr

Member, Board of Directors
Kevin Starr is a proven operational leader with over 25 years' experience building and operating leading biotech companies. Mr. Starr co-founded Third Rock Ventures in 2007 and focuses on the formation, development and business strategy of its portfolio companies as well as actively identifying and evaluating new investments. He also assumes active leadership roles in Third Rock portfolio companies. Prior to Third Rock Ventures, Mr. Starr was chief operating officer and chief financial officer at Millennium Pharmaceuticals, where he led efforts to raise billions of dollars in capital through strategic alliances and public financing and drove growth through company expansion and mergers and acquisitions. Earlier in his career, he served in various executive roles at Millennium BioTherapeutics, Biogen and Digital Equipment Corporation. Mr. Starr holds an M.S. in corporate finance from Boston College and a B.A. in mathematics and business from Colby College. He is a Board Member of Alnylam Pharmaceuticals and also serves on the Board of Directors for Afferent Pharmaceuticals, Agios Pharmaceuticals and Zafgen, Inc.


Our Team - SAGE Therapeutics

www.sagerx.com [cached]

Kevin Starr

Kevin is a proven operational leader with more than 25 years of experience building and operating leading biotech companies. Kevin co-founded Third Rock Ventures in 2007 and focuses on the formation, development and business strategy of the firm's portfolio companies as well as actively identifying and evaluating new investments. Prior to Third Rock Ventures, Kevin was Chief Operating Officer and Chief Financial Officer at Millennium Pharmaceuticals, where he led key roles in raising billions of dollars in capital through strategic alliances and public financing and driving growth through company expansion and mergers and acquisitions. Earlier in his career, he served in various executive roles at Millennium BioTherapeutics, Biogen and Digital Equipment Corporation. He is currently a Board Member of Alnylam Pharmaceuticals.
Kevin holds a M.S. in Corporate Finance from Boston College and a B.A. in Mathematics and Business from Colby College.


Our People Third Rock Ventures

www.thirdrockventures.com [cached]

Kevin Starr

Partner
Kevin Starr is a co-founder of Third Rock Ventures with more than 25 years of experience building and leading biotechnology companies. Kevin's focus has been on the formation, development and strategic governance of our portfolio companies. He has been actively identifying and evaluating new investments for our first three funds, where he also helped successfully raise $1.3 billion for Third Rock. Kevin contributes as an advisor to our Fund IV portfolio companies and will continue to play active board roles in our current Fund I, II and III portfolio companies. In many of these companies, Kevin functioned as chief executive officer through the first 12-18 months after launch. His portfolio company roles include:
...
Prior to Third Rock, Kevin served as chief operating officer and chief financial officer at Millennium Pharmaceuticals, where he helped raise billions of dollars in capital through strategic alliances and public financing and drove the company's growth through organic expansion and mergers and acquisitions. Earlier in his career, he served in various executive roles at Biogen and Digital Equipment Corporation. He is currently a board member of Alnylam Pharmaceuticals. Kevin holds an M.S. in corporate finance from Boston College and a B.A. in mathematics and business from Colby College.
Kevin is a founding investor in Prospect Pictures, which produced the hit Broadway show turned movie "Rock of Ages."
...
Kevin Starr
Partner


Zafgen, Inc. - Definitive Proxy Statement

ir.zafgen.com [cached]

Kevin P. Starr

Director
...
Kevin P. Starr . Mr. Starr has served as a member of our Board of Directors since December 2006. In April 2007, Mr. Starr co-founded Third Rock Ventures, a venture capital firm where he remains a partner. From January 2003 to March 2007, Mr. Starr undertook a number of entrepreneurial endeavors in the life science and entertainment industries. From December 2001 to December 2002, Mr. Starr served as chief operating officer of Millennium Pharmaceuticals, Inc. He also served as Millennium’s chief financial officer from December 1998 to December 2002. Mr. Starr currently serves on the Board of Directors of Agios Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc. and SAGE Therapeutics. Mr. Starr received an M.S. in corporate finance from Boston College and a B.S./B.A. in mathematics and business from Colby College. Mr. Starr’s qualifications to serve on our Board of Directors include his executive management roles with responsibility over key financial and business planning functions and experience in the formation, development and business strategy of multiple start-up companies in the life sciences sector.
...
Kevin P. Starr (11)
...
Investment decisions with respect to the shares held by TRV LP are made by an investment committee at TRV GP comprised of Mark Levin, Kevin Starr and Bob Tepper.
...
Mr. Starr is a member of our Board of Directors.
...
Consists of 9,356 shares of common stock Mr. Starr holds in his individual capacity, of which 1,248 shares of common stock are subject to restrictions under a Restricted Stock Agreement, which lapse over a period of one year starting January 1, 2015 on a quarterly basis in arrears.
...
During 2014, Peter Barrett, Ph.D., John L. LaMattina, Ph.D. and Kevin P. Starr served on the compensation committee, which was chaired by John L. LaMattina, Ph.D. None of the members of our compensation committee has at any time during the last three years been one of our officers or employees or had any relationship requiring disclosure under Item 404 of Regulation S-K.
...
Frances K. Heller, Kevin P. Starr and Frank E. Thomas serve on the audit committee, which is chaired by Frank E. Thomas.
...
Our board has determined that while Kevin Starr satisfies the independence requirements under applicable NASDAQ Stock Market rules, he does not satisfy the independence requirements of the SEC applicable to members of audit committees.
...
Peter Barrett, Ph.D., John L. LaMattina, Ph.D. and Kevin P. Starr serve on the compensation committee, which is chaired by John L. LaMattina, Ph.D.
...
Peter Barrett, Ph.D. and Kevin P. Starr serve on the nominating and corporate governance committee, which is chaired by Peter Barrett, Ph.D.
...
Kevin P. Starr
...
Kevin P. Starr
...
Kevin P. Starr


MyoKardia

www.myokardia.com [cached]

Kevin Starr Co-Founder and Partner, Third Rock Ventures

Kevin Starr is a proven operational leader with more than 25 years of experience building and operating leading biotech companies. Mr. Starr co-founded Third Rock Ventures in 2007 and focuses on the formation, development and business strategy of the firm's portfolio companies as well as actively identifying and evaluating new investments. In addition to his role at Third Rock, he also serves as the interim chief executive officer of SAGE Therapeutics. Prior to Third Rock Ventures, Mr. Starr was chief operating officer and chief financial officer at Millennium Pharmaceuticals, where he led key roles in raising billions of dollars in capital through strategic alliances and public financing and driving growth through company expansion and mergers and acquisitions. Earlier in his career, he served in various executive roles at Millennium BioTherapeutics, Biogen and Digital Equipment Corporation. He is currently a board member of Alnylam Pharmaceuticals and SAGE Therapeutics.
Mr. Starr holds a M.S. in corporate finance from Boston College and a B.A. in mathematics and business from Colby College.

Similar Profiles

Other People with this Name

Other people with the name Starr

Jeanette Starr
Dechert LLP

Alicia Starr
Avondale College Ltd

Sarah Starr
Sony Corporation

Jason Starr
CoxReps

Marisa Starr
National Institutes of Health

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory